Articles by Disease (Ventricular Dysfunction )

Consequences of Elevated Homocysteine During Embryonic Development and Possible Modes of Action

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2719-2732
Author(s): P. R. Brauer and B. J. Tierney

Teratological Consequences of Nitric Oxide Synthesis Inhibition

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2759-2767
Author(s): Gian Mario Tiboni and Ettore Clementini

Pleiotropic Actions of PPARg Activators Thiazolidinediones in Cardiovascular Diseases

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2779-2786
Author(s): Hiroyuki Takano, Hiroshi Hasegawa, Yunzeng Zou and Issei Komuro

Protein Kinase C and Prostate Carcinogenesis: Targeting the Cell Cycle and Apoptotic Mechanisms

Journal: Current Drug Targets
Volume: 5
Page: 431-443
Author(s): M. Veronica Gavrielides, Anita F. Frijhoff, Claudio J. Conti and Marcelo G. Kazanietz

Secondary Prevention of Ischemic Stroke

Journal: Current Drug Targets
Volume: 5
Page: 457-472
Author(s): Kirsi Rantanen and Turgut Tatlisumak

Acute Stroke Therapy: Combination Drugs and Multifunctional Neuroprotectants

Journal: Current Neuropharmacology
Volume: 2
Page: 277-294
Author(s): Jennifer K. Callaway

Possible Neuroprotective Strategies for Huntingtons Disease

Journal: Current Neuropharmacology
Volume: 2
Page: 331-342
Author(s): James G. Greene

The Therapeutic Role of Taurine in Ischaemia-Reperfusion Injury

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2401-2410
Author(s): R. Kingston, C. J. Kelly and P. Murray

Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2131-2143
Author(s): Enriquez P and Bullock R.

Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2193-2204
Author(s): J. Sahuquillo, M. P. Mena, A. Vilalta and M. A. Poca